Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 11:46AM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.78 Insider Own3.76% Shs Outstand58.56M Perf Week19.20%
Market Cap244.69M Forward P/E- EPS next Y-0.14 Insider Trans-55.48% Shs Float56.61M Perf Month32.91%
Income-45.69M PEG- EPS next Q-0.11 Inst Own59.62% Short Float3.40% Perf Quarter50.18%
Sales0.00M P/S- EPS this Y37.10% Inst Trans-1.08% Short Ratio2.05 Perf Half Y-45.69%
Book/sh2.08 P/B2.00 EPS next Y78.40% ROA-27.12% Short Interest1.93M Perf Year-41.33%
Cash/sh2.44 P/C1.71 EPS next 5Y- ROE-32.04% 52W Range1.42 - 11.97 Perf YTD18.52%
Dividend Est.- P/FCF- EPS past 5Y5.38% ROI-36.36% 52W High-65.25% Beta1.52
Dividend TTM- Quick Ratio6.67 Sales past 5Y0.00% Gross Margin- 52W Low192.96% ATR (14)0.23
Dividend Ex-Date- Current Ratio6.67 EPS Y/Y TTM30.15% Oper. Margin0.00% RSI (14)69.11 Volatility5.52% 5.56%
Employees15 Debt/Eq0.13 Sales Y/Y TTM- Profit Margin- Recom1.29 Target Price9.00
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q44.26% Payout- Rel Volume1.58 Prev Close3.62
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume941.10K Price4.16
SMA2021.78% SMA5024.80% SMA200-25.51% Trades Volume568,656 Change14.92%
Date Action Analyst Rating Change Price Target Change
Apr-27-22Resumed H.C. Wainwright Buy $15
Feb-08-21Initiated H.C. Wainwright Buy $26
Dec-16-20Initiated Berenberg Buy $32
Oct-30-20Initiated Jefferies Buy $24
Oct-16-20Initiated BTIG Research Buy $29
Sep-22-20Initiated Alliance Global Partners Buy $32
May-12-20Initiated Oppenheimer Outperform $12
Dec-04-18Initiated Citigroup Buy $23
Sep-26-18Reiterated Cantor Fitzgerald Overweight $23 → $30
Sep-13-18Initiated Janney Buy
Feb-06-24 07:00AM
Jan-04-24 07:00AM
Dec-19-23 07:27AM
04:01PM Loading…
Dec-18-23 04:01PM
Dec-06-23 11:55AM
Dec-05-23 09:00AM
Nov-27-23 04:07PM
Nov-01-23 10:34AM
Oct-18-23 08:30AM
Oct-17-23 10:13AM
Aug-28-23 10:22AM
Jul-20-23 09:55AM
07:00AM Loading…
Jul-06-23 07:00AM
Jun-29-23 07:00AM
Jun-28-23 04:01PM
Jun-27-23 12:03PM
Jun-26-23 04:01PM
Jun-23-23 07:00AM
Jun-21-23 09:34AM
Jun-16-23 10:26AM
Jun-15-23 02:52PM
Jun-14-23 04:01PM
Jun-02-23 07:00AM
07:30AM Loading…
May-07-23 07:30AM
May-04-23 07:00AM
Apr-13-23 07:00AM
Apr-06-23 07:00AM
Mar-30-23 07:00AM
Mar-16-23 07:00AM
Mar-11-23 02:59AM
Mar-09-23 11:05PM
Mar-02-23 07:00AM
Mar-01-23 07:00AM
Feb-28-23 03:22PM
Feb-23-23 07:00AM
Feb-22-23 05:26AM
Feb-16-23 07:00AM
Feb-09-23 07:00AM
Feb-07-23 07:00AM
Jan-12-23 06:37AM
Dec-21-22 07:00AM
Dec-13-22 01:37PM
Dec-01-22 08:00AM
Nov-29-22 08:00AM
Nov-10-22 07:00AM
Nov-03-22 08:00AM
Nov-02-22 01:45PM
Oct-26-22 08:00AM
Oct-06-22 12:23PM
Oct-05-22 04:05PM
Sep-14-22 08:00AM
Sep-07-22 08:00AM
Sep-01-22 06:56AM
Aug-15-22 09:55AM
Aug-07-22 03:00AM
Aug-05-22 07:00AM
Aug-01-22 02:55PM
Jul-29-22 08:00AM
Jul-13-22 10:53AM
Jul-12-22 09:00AM
Jul-11-22 04:05PM
Jun-28-22 12:20PM
Jun-21-22 11:01AM
Jun-09-22 08:00AM
Jun-08-22 09:40AM
Jun-07-22 04:05PM
May-24-22 07:00AM
May-23-22 04:05PM
May-18-22 03:26PM
May-05-22 08:30PM
May-04-22 08:30AM
Apr-28-22 04:05PM
Apr-27-22 08:00AM
Apr-21-22 08:00AM
Apr-05-22 08:00AM
Mar-29-22 08:00AM
Mar-22-22 08:00AM
Mar-18-22 07:30AM
Mar-17-22 07:00AM
Mar-14-22 08:00AM
Mar-10-22 08:00AM
Mar-08-22 08:00AM
Mar-07-22 11:28AM
Feb-10-22 08:00AM
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PERCEPTIVE ADVISORS LLC10% OwnerOct 18Sale1.74306,499533,3088,593,586Oct 18 05:15 PM
PERCEPTIVE ADVISORS LLC10% OwnerOct 16Sale1.602,450,0003,920,0008,900,085Oct 18 05:15 PM
Brady Todd CPresident and CEOSep 07Option Exercise0.55273,058150,7281,728,343Sep 11 05:42 PM
Phillips Gary M.DirectorSep 07Option Exercise0.555,4373,00114,812Sep 11 04:31 PM
Walker NealDirectorAug 22Option Exercise0.559,6045,30115,854Aug 24 04:13 PM
Bronstein BenDirectorJun 27Option Exercise0.559,6045,30128,248Jun 29 04:23 PM